by Lisa Jarvis A Texas federal judge’s ruling to remove the 23-year-old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s also an appalling sideswipe at the Food and Drug Administration’s authority and expertise. And if allowed to ...
by Jennifer Shinall Over the New Year’s holiday, my husband and I received the surprise of our lives: a positive pregnancy test. The pregnancy was unplanned, but very welcome. Getting pregnant with our first two children had been somewhat of a grand undertaking, so the idea that I ...
by John M. Crisp Is all politics truly local? If so, how do we account for many of the priorities on the list of the bills that my home state’s legislature hopes to pass this year? Texas is so devoted to small government that its legislature is limited to only one 140-day session ...
Good: SB 216, requiring all schools to instruct students on Holocaust, other genocides and financial literacy. This bill has passed the Senate and is being reviewed by the House Education Committee. We give two thumbs up for the requirement to teach financial literacy. Not everyone needs ...
The war over abortion rights has moved from the sidewalks in front of medical clinics to pharmacies and mailboxes. The Food and Drug Administration’s loosening of restrictions on abortion pills has provided some degree of protection to women in the post-Roe v. Wade world. But it also has ...
Women’s Health Center of West Virginia, which had been the state’s last abortion clinic, has filed a federal lawsuit over the ban passed last fall. The plaintiffs are asking the U.S. District Court for the Southern District of West Virginia to issue an injunction to block the entire ...